{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:37:02Z","timestamp":1762421822194,"version":"build-2065373602"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019256","name":"NIHR Great Ormond Street Hospital Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210774\/Z\/18\/"],"award-info":[{"award-number":["210774\/Z\/18\/"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011724","name":"Muscular Dystrophy UK","doi-asserted-by":"publisher","award":["17GRO-PG36-0165"],"award-info":[{"award-number":["17GRO-PG36-0165"]}],"id":[{"id":"10.13039\/100011724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001279","name":"Great Ormond Street Hospital Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.omtm.2022.04.015","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T11:53:44Z","timestamp":1651492424000},"page":"491-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8405-8140","authenticated-orcid":false,"given":"Jinhong","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3322-6159","authenticated-orcid":false,"given":"Marc","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Counsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Popplewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0375-476X","authenticated-orcid":false,"given":"Jennifer","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2022.04.015_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4684-4907-5_26","article-title":"Genetic analysis of Duchenne dystrophy","volume":"182","author":"Kunkel","year":"1985","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omtm.2022.04.015_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.omtm.2022.04.015_bib3","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1566523215666150710123830","article-title":"Adeno-associated virus (AAV) mediated dystrophin gene transfer studies and exon skipping strategies for duchenne muscular dystrophy (DMD)","volume":"15","author":"Kawecka","year":"2015","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1089\/hum.2013.210","article-title":"Full-length dystrophin reconstitution with adeno-associated viral vectors","volume":"25","author":"Lostal","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib6","doi-asserted-by":"crossref","first-page":"S317","DOI":"10.3233\/JND-210683","article-title":"Changes in myonuclear number during postnatal growth -implications for AAV gene therapy for muscular dystrophy","volume":"8","author":"Morgan","year":"2021","journal-title":"J.\u00a0Neuromuscul. Dis."},{"key":"10.1016\/j.omtm.2022.04.015_bib7","doi-asserted-by":"crossref","first-page":"12979","DOI":"10.1073\/pnas.202300099","article-title":"Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin","volume":"99","author":"DelloRusso","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omtm.2022.04.015_bib8","first-page":"965","article-title":"In\u00a0vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes","volume":"3","author":"Clemens","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/gt.2008.8","article-title":"Full-length dystrophin gene transfer to the mdx mouse in utero","volume":"15","author":"Reay","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1521-2254(199907\/08)1:4<280::AID-JGM45>3.0.CO;2-L","article-title":"Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle","volume":"1","author":"Akkaraju","year":"1999","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2022.04.015_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/hum.2019.224","article-title":"Restoration of functional full-length dystrophin after intramuscular transplantation of Foamy Virus-transduced myoblasts","volume":"31","author":"Meng","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib12","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1038\/s41598-017-08312-3","article-title":"Delivery of large transgene cassettes by foamy virus vector","volume":"7","author":"Sweeney","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2022.04.015_bib13","doi-asserted-by":"crossref","first-page":"44775","DOI":"10.1038\/srep44775","article-title":"Lentiviral vectors can be used for full-length dystrophin gene therapy","volume":"7","author":"Counsell","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2022.04.015_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2005.05.010","article-title":"Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche","volume":"122","author":"Collins","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2022.04.015_bib15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature07384","article-title":"Self-renewal and expansion of single transplanted muscle stem cells","volume":"456","author":"Sacco","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2022.04.015_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nmd.2011.09.008","article-title":"185th ENMC International Workshop: stem\/precursor cells as a therapeutic strategy for muscular dystrophies 3\u20135 June 2011, Naarden, The Netherlands","volume":"22","author":"Patel","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2022.04.015_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ncb1542","article-title":"Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells","volume":"9","author":"Dellavalle","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omtm.2022.04.015_bib18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/NEN.0b013e31822a6baa","article-title":"Transplanted myoblasts can migrate several millimeters to fuse with damaged myofibers in nonhuman primate skeletal muscle","volume":"70","author":"Skuk","year":"2011","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omtm.2022.04.015_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3727\/096368912X661337","article-title":"Intramuscular transplantation of myogenic cells in primates: importance of needle size, cell number, and injection volume","volume":"23","author":"Skuk","year":"2014","journal-title":"Cell Transpl."},{"key":"10.1016\/j.omtm.2022.04.015_bib20","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1097\/01.TP.0000131175.60047.EB","article-title":"Growth factors improve the in\u00a0vivo migration of human skeletal myoblasts by modulating their endogenous proteolytic activity","volume":"77","author":"Lafreniere","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.omtm.2022.04.015_bib21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3727\/096368909X470900","article-title":"Growth factor coinjection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success","volume":"18","author":"Lafreniere","year":"2009","journal-title":"Cell Transpl."},{"key":"10.1016\/j.omtm.2022.04.015_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-med-081117-010451","article-title":"CRISPR correction of duchenne muscular dystrophy","volume":"70","author":"Min","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.omtm.2022.04.015_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.bbmt.2015.01.013","article-title":"Comparison of survival in patients with T\u00a0cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease","volume":"21","author":"Beitinjaneh","year":"2015","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.omtm.2022.04.015_bib24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/mus.880170905","article-title":"Use of antibodies to identify satellite cells with a light microscope","volume":"17","author":"Zhang","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2022.04.015_bib25","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/nm.3990","article-title":"Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division","volume":"21","author":"Dumont","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2022.04.015_bib26","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.3390\/ijms21197168","article-title":"Effects of mini-dystrophin on dystrophin-deficient, human skeletal muscle-derived cells","volume":"21","author":"Meng","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2022.04.015_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10974-019-09535-9","article-title":"What is the level of dystrophin expression required for effective therapy of Duchenne muscular dystrophy?","volume":"40","author":"Wells","year":"2019","journal-title":"J.\u00a0Muscle Res. Cell Motil."},{"key":"10.1016\/j.omtm.2022.04.015_bib28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.nmd.2018.02.013","article-title":"Low dystrophin levels are insufficient to normalize the neuromuscular synaptic abnormalities of mdx mice","volume":"28","author":"van der Pijl","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2022.04.015_bib29","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1093\/hmg\/ddv155","article-title":"How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse","volume":"24","author":"Godfrey","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2022.04.015_bib30","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.2353\/ajpath.2008.071042","article-title":"Preservation of muscle force in Mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein","volume":"172","author":"Li","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2022.04.015_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/mt.2010.213","article-title":"Physiological characterization of muscle strength with variable levels of dystrophin restoration in mdx mice following local antisense therapy","volume":"19","author":"Sharp","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib32","doi-asserted-by":"crossref","first-page":"e31937","DOI":"10.1371\/journal.pone.0031937","article-title":"The effects of low levels of dystrophin on mouse muscle function and pathology","volume":"7","author":"van","year":"2012","journal-title":"PLoS. One."},{"key":"10.1016\/j.omtm.2022.04.015_bib33","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1096\/fj.12-224170","article-title":"Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin\/utrophin double-knockout mice","volume":"27","author":"van","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2022.04.015_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pep.2015.02.002","article-title":"Codon optimization of genes for efficient protein expression in mammalian cells by selection of only preferred human codons","volume":"109","author":"Inouye","year":"2015","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.omtm.2022.04.015_bib35","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.molmed.2014.09.003","article-title":"A critical analysis of codon optimization in human therapeutics","volume":"20","author":"Mauro","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtm.2022.04.015_bib36","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/mt.2008.186","article-title":"Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2\/8 gene transfer","volume":"16","author":"Foster","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib37","doi-asserted-by":"crossref","first-page":"16105","DOI":"10.1038\/ncomms16105","article-title":"Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy","volume":"8","author":"Le","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2022.04.015_bib38","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of systemic delivery of rAAVrh74.MHCK7.micro-dystrophin in children with duchenne muscular dystrophy: a nonrandomized controlled trial","volume":"77","author":"Mendell","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.omtm.2022.04.015_bib39","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/gt.2008.104","article-title":"Construction and analysis of compact muscle-specific promoters for AAV vectors","volume":"15","author":"Wang","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61737-982-6_1","article-title":"Design and testing of regulatory cassettes for optimal activity in skeletal and cardiac muscles","volume":"709","author":"Himeda","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2022.04.015_bib41","doi-asserted-by":"crossref","first-page":"e17454","DOI":"10.1371\/journal.pone.0017454","article-title":"Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice","volume":"6","author":"Meng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2022.04.015_bib42","doi-asserted-by":"crossref","first-page":"19750","DOI":"10.1038\/srep19750","article-title":"Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy","volume":"6","author":"Meng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2022.04.015_bib43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/345315a0","article-title":"Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle","volume":"345","author":"Ervasti","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2022.04.015_bib44","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1083\/jcb.115.6.1685","article-title":"Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice","volume":"115","author":"Ohlendieck","year":"1991","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omtm.2022.04.015_bib45","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.43.4.795","article-title":"Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma","volume":"43","author":"Ohlendieck","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2022.04.015_bib46","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1242\/jcs.115.14.2801","article-title":"The dystrophin-associated protein complex","volume":"115","author":"Ehmsen","year":"2002","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.omtm.2022.04.015_bib47","doi-asserted-by":"crossref","first-page":"33501","DOI":"10.1074\/jbc.M111.227678","article-title":"The dystrophin-associated protein complex maintains muscle excitability by regulating Ca(2+)-dependent K(+) (BK) channel localization","volume":"286","author":"Sancar","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2022.04.015_bib48","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/sj.embor.7400140","article-title":"Dystroglycan, a scaffold for the ERK\u2013MAP kinase cascade","volume":"5","author":"Spence","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.omtm.2022.04.015_bib49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/mt.2011.248","article-title":"Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy","volume":"20","author":"Cirak","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2022.04.015_bib51","doi-asserted-by":"crossref","first-page":"e0150818","DOI":"10.1371\/journal.pone.0150818","article-title":"Correlation of utrophin levels with the dystrophin protein complex and muscle fibre regeneration in duchenne and becker muscular dystrophy muscle biopsies","volume":"11","author":"Janghra","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2022.04.015_bib52","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(09)70211-X","article-title":"Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study","volume":"8","author":"Kinali","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtm.2022.04.015_bib53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-020-00918-5","article-title":"A high-throughput digital script for multiplexed immunofluorescent analysis and quantification of sarcolemmal and sarcomeric proteins in muscular dystrophies","volume":"8","author":"Scaglioni","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.omtm.2022.04.015_bib54","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1073\/pnas.1013067108","article-title":"Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice","volume":"108","author":"Amenta","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omtm.2022.04.015_bib55","doi-asserted-by":"crossref","first-page":"e1004431","DOI":"10.1371\/journal.pgen.1004431","article-title":"Muscle structure influences utrophin expression in mdx mice","volume":"10","author":"Banks","year":"2014","journal-title":"PLoS| Genet."},{"key":"10.1016\/j.omtm.2022.04.015_bib56","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.omtm.2022.04.015_bib57","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2022.04.015_bib58","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.omtm.2022.04.015_bib59","doi-asserted-by":"crossref","first-page":"eaan8081","DOI":"10.1126\/scitranslmed.aan8081","article-title":"Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy","volume":"9","author":"Amoasii","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2022.04.015_bib60","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","article-title":"A single CRISPR-cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells","volume":"18","author":"Young","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2022.04.015_bib61","doi-asserted-by":"crossref","first-page":"e13228","DOI":"10.15252\/emmm.202013228","article-title":"Targeted genome editing in\u00a0vivo corrects a Dmd duplication restoring wild-type dystrophin expression","volume":"13","author":"Maino","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2022.04.015_bib62","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Dystrophin immunity in Duchenne's muscular dystrophy","volume":"363","author":"Mendell","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2022.04.015_bib63","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1093\/hmg\/ddz128","article-title":"AAV-based gene therapies for the muscular dystrophies","volume":"28","author":"Crudele","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2022.04.015_bib64","doi-asserted-by":"crossref","first-page":"13714","DOI":"10.1073\/pnas.240335297","article-title":"Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model","volume":"97","author":"Wang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omtm.2022.04.015_bib65","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.molmed.2020.09.010","article-title":"Journey to the center of the cell: tracing the path of AAV transduction","volume":"27","author":"Dhungel","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtm.2022.04.015_bib66","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/mt.2013.244","article-title":"Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery","volume":"22","author":"Chicoine","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib67","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.omtm.2019.01.008","article-title":"Capsid modifications for targeting and improving the efficacy of AAV vectors","volume":"12","author":"Buning","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2022.04.015_bib68","doi-asserted-by":"crossref","first-page":"197716","DOI":"10.1016\/j.virusres.2019.197716","article-title":"Molecular characterization of novel Adeno-associated virus variants infecting human tissues","volume":"272","author":"Purohit","year":"2019","journal-title":"Virus. Res."},{"key":"10.1016\/j.omtm.2022.04.015_bib69","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/mt.2015.146","article-title":"Oral-tolerization prevents immune responses and improves transgene persistence following gene transfer mediated by adeno-associated viral vector","volume":"24","author":"Hardet","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib70","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1038\/s41467-018-06621-3","article-title":"Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration","volume":"9","author":"Meliani","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2022.04.015_bib71","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1182\/blood-2007-03-080093","article-title":"Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver","volume":"110","author":"Mingozzi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2022.04.015_bib72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mt.2009.253","article-title":"Dystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression","volume":"18","author":"Kimura","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib73","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/jgm.649","article-title":"Transduction of satellite cells after prenatal intramuscular administration of lentiviral vectors","volume":"7","author":"MacKenzie","year":"2005","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.omtm.2022.04.015_bib74","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.omtm.2022.04.015_bib75","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2022.04.015_bib76","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.omtm.2022.04.015_bib77","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2022.04.015_bib78","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2022.04.015_bib79","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T\u00a0cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2022.04.015_bib80","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1128\/JVI.79.21.13463-13472.2005","article-title":"The retroviral capsid domain dictates virion size, morphology, and coassembly of gag into virus-like particles","volume":"79","author":"Ako-Adjei","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2022.04.015_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2013.03.015","article-title":"Characterization and comparative performance of lentiviral vector preparations concentrated by either one-step ultrafiltration or ultracentrifugation","volume":"175","author":"Papanikolaou","year":"2013","journal-title":"Virus. Res."},{"key":"10.1016\/j.omtm.2022.04.015_bib82","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/mt.2009.256","article-title":"Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome \u22658.2\u00a0kb","volume":"18","author":"Lai","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib83","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.mt.6300047","article-title":"Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models","volume":"15","author":"Quenneville","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib84","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1089\/hum.2004.15.1109","article-title":"Human muscle precursor cell regeneration in the mouse host is enhanced by growth factors","volume":"15","author":"Brimah","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib85","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1089\/104303403322168000","article-title":"Extended amplification in\u00a0vitro and replicative senescence: key factors implicated in the success of human myoblast transplantation","volume":"14","author":"Cooper","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib86","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/mt.2014.26","article-title":"Human skeletal muscle-derived CD133(+) cells form functional satellite cells after intramuscular transplantation in immunodeficient host mice","volume":"22","author":"Meng","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib87","doi-asserted-by":"crossref","first-page":"E6117","DOI":"10.1073\/pnas.1606724113","article-title":"Codon usage is an important determinant of gene expression levels largely through its effects on transcription","volume":"113","author":"Zhou","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omtm.2022.04.015_bib88","first-page":"197","article-title":"Codon-optimized genes that enable increased heterologous expression in mammalian cells and elicit efficient immune responses in mice after vaccination of naked DNA","volume":"94","author":"Graf","year":"2004","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.omtm.2022.04.015_bib89","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1085","article-title":"Systemic delivery of genes to striated muscles using adeno-associated viral vectors","volume":"10","author":"Gregorevic","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2022.04.015_bib90","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mt.6300027","article-title":"Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle","volume":"15","author":"Salva","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib91","doi-asserted-by":"crossref","first-page":"dmm042192","DOI":"10.1242\/dmm.042192","article-title":"Skeletal muscle in health and disease","volume":"13","author":"Morgan","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtm.2022.04.015_bib92","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/mt.2009.267","article-title":"Desmin-regulated lentiviral vectors for skeletal muscle gene transfer","volume":"18","author":"Talbot","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib93","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2174\/1566523214666140612154521","article-title":"The human desmin promoter drives robust gene expression for skeletal muscle stem cell-mediated gene therapy","volume":"14","author":"Jonuschies","year":"2014","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib94","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/mt.2012.189","article-title":"Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation","volume":"20","author":"Bencze","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib95","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/104303401750148784","article-title":"A new immunodeficient mouse model for human myoblast transplantation","volume":"12","author":"Cooper","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib96","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.nmd.2007.04.009","article-title":"Human muscle precursor cells give rise to functional satellite cells in\u00a0vivo","volume":"17","author":"Ehrhardt","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2022.04.015_bib97","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.stemcr.2018.01.022","article-title":"High-yield purification, preservation, and serial transplantation of human satellite cells","volume":"10","author":"Garcia","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omtm.2022.04.015_bib98","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1038\/s41598-017-03703-y","article-title":"Human myogenic reserve cells are quiescent stem cells that contribute to muscle regeneration after intramuscular transplantation in immunodeficient mice","volume":"7","author":"Laumonier","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2022.04.015_bib99","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI63992","article-title":"Human satellite cells have regenerative capacity and are genetically manipulable","volume":"124","author":"Marg","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2022.04.015_bib100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/mt.2011.193","article-title":"Slowing down differentiation of engrafted human myoblasts into immunodeficient mice correlates with increased proliferation and migration","volume":"20","author":"Riederer","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib101","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3727\/000000005783982837","article-title":"Comparative analysis of genetically engineered immunodeficient mouse strains as recipients for human myoblast transplantation","volume":"14","author":"Silva-Barbosa","year":"2005","journal-title":"Cell Transpl."},{"key":"10.1016\/j.omtm.2022.04.015_bib102","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/mt.2010.128","article-title":"Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cells","volume":"18","author":"Skuk","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib103","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.stemcr.2015.07.016","article-title":"Human satellite cell transplantation and regeneration from diverse skeletal muscles","volume":"5","author":"Xu","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omtm.2022.04.015_bib104","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13395-020-00228-3","article-title":"Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I","volume":"10","author":"Azzag","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtm.2022.04.015_bib105","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","article-title":"Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice","volume":"10","author":"Darabi","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2022.04.015_bib106","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41556-017-0010-2","article-title":"ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs","volume":"20","author":"Hicks","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omtm.2022.04.015_bib107","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.stemcr.2020.06.004","article-title":"Induced fetal human muscle stem cells with high therapeutic potential in a mouse muscular dystrophy model","volume":"15","author":"Zhao","year":"2020","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omtm.2022.04.015_bib108","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1126\/science.1114758","article-title":"Direct isolation of satellite cells for skeletal muscle regeneration","volume":"309","author":"Montarras","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.omtm.2022.04.015_bib109","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13395-015-0036-8","article-title":"The effect of the muscle environment on the regenerative capacity of human skeletal muscle stem cells","volume":"5","author":"Meng","year":"2015","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtm.2022.04.015_bib110","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/mt.2013.186","article-title":"The Rag2 (-)\/Il2rb(-)\/Dmd (-) mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies","volume":"21","author":"Vallese","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.04.015_bib111","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/stem.1158","article-title":"Donor satellite cell engraftment is significantly augmented when the host niche is preserved and endogenous satellite cells are incapacitated","volume":"30","author":"Boldrin","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.omtm.2022.04.015_bib112","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/hum.2013.126","article-title":"Mouse regenerating myofibers detected as false-positive donor myofibers with anti-human spectrin","volume":"25","author":"Rozkalne","year":"2014","journal-title":"Hum. Gene Ther."}],"container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050122000638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050122000638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:33:37Z","timestamp":1762421617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050122000638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":112,"alternative-id":["S2329050122000638"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2022.04.015","relation":{},"ISSN":["2329-0501"],"issn-type":[{"type":"print","value":"2329-0501"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2022.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}